Description
Molsidomine is a NO donor that exhibits vasodilatory, cardioprotective, anti-atherosclerotic, and anticoagulant activities. Molsidomine inhibits PDGF-induced smooth muscle cell migration and proliferation and suppresses carotid artery neointima formation in vivo by inhibiting activity of annexin A2. In vitro, molsidomine inhibits activated platelet adhesion.